The University of Chicago Header Logo

Connection

Hedy Kindler to Injections, Intravenous

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Injections, Intravenous.
Hedy Kindler
Connection Strength
0.018
Injections, Intravenous
  1. Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers. Clin Cancer Res. 2007 Sep 01; 13(17):5144-9.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.